NAVIDEA BIOPHARMACEUTICALS, INC. | 2013 | FY | 3


The following table summarizes information about our outstanding warrants at December 31, 2013:
 
Exercise
Price
 
Number of
Warrants
 
Expiration Date
Series BB
$
2.00

 
300,000

 
July 2015
Series EE
2.375

 
134,211

 
August 2015
Series FF
1.97

 
30,000

 
December 2015
Series GG
2.10

 
333,333

 
December 2016
Series HH
2.49

 
301,205

 
June 2023
Series II
3.04

 
275,000

 
June 2018
Series JJ
3.83

 
3,169,015

 
September 2016
 
$
3.39

(1) 
4,542,764

 
 

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock